Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared to Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients Geno2/3

ClinicalTrials.gov ID: NCT00411385

Public ClinicalTrials.gov record NCT00411385. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 25, 2026, 12:01 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase3 Study to Evaluate the Efficacy and Safety of AlbuminInterferon in Combination With Ribavirin Compared With Peginterferon in Combination With Ribavirin in Interferon Alfa Naive Subjects With CHC Genotype 2/3.

Study identification

NCT ID
NCT00411385
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Human Genome Sciences Inc.
Industry
Enrollment
933 participants

Conditions and interventions

Interventions

  • albumin interferon alfa-2b Drug
  • peginterferon alfa-2a Drug
  • Ribavirin Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2007
Primary completion
Sep 30, 2008
Completion
Sep 30, 2008
Last update posted
Aug 7, 2013

2007 – 2008

United States locations

U.S. sites
28
U.S. states
16
U.S. cities
23
Facility City State ZIP Site status
Mayo Clinic Hospital Phoenix Arizona 85054
Scripps Clinic La Jolla California 92037
California Pacific Medical Center San Francisco California 94115
University of Colorado Denver Colorado 80262-0001
University of Florida-Gainesville Gainesville Florida 32610
Shands Jacksonville Medical Center Jacksonville Florida 32209
Mayo Clinic Transplant Center Jacksonville Florida 32216
University of Miami Miami Florida 33136-1051
Atlanta Gastroenterology Associates Atlanta Georgia 30308
GI of Atlanta Atlanta Georgia 30309
University of Chicago Hospital Chicago Illinois 60637
Johns Hopkins Center for Viral Hepatits Baltimore Maryland 21287
Beth Israel Deaconess Medical Center Boston Massachusetts 02215
Minnesota Gastroenterology, P.A. Plymouth Minnesota 55446
Dartmouth Hitchcock Medical Center Lebanon New Hampshire 03756
University of New Mexico Albuquerque New Mexico 87131-0001
New York Hospital - Cornell New York New York 10021
Faculty Practice Associates New York New York 10029
NY Presbyterian Medical Center - Columbia Univ. Med Center New York New York 10032
Bronx VA Medical Center The Bronx New York 10468
University of North Carolina at Chapel Hill Chapel Hill North Carolina 27599-7584
Regional Gastroenterology Associates of Lancaster, Ltd. Lancaster Pennsylvania 17604-3200
Thomas Jefferson University Philadelphia Pennsylvania 19107
Temple University Hospital Philadelphia Pennsylvania 19140
Baylor University Medical Center Dallas Texas 75246
Brooke Army Medical Center Fort Sam Houston Texas 78234
Alamo Medrical Research San Antonio Texas 78215
Metropolitan Research Fairfax Virginia 22031

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 131 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00411385, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 7, 2013 · Synced Jun 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00411385 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →